New insider activity at Molina Healthcare ( (MOH) ) has taken place on August 8, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Director Ronna Romney recently sold 700 shares of Molina Healthcare stock, generating a total of $107,618 from the transaction.
Recent Updates on MOH stock
Molina Healthcare has experienced a series of price target reductions and downgrades from multiple financial analysts due to various concerns. UBS lowered its price target citing higher cost trends leading to an uncertain outlook. BofA’s adjustment was influenced by the company’s guidance on future earnings per share (EPS), prompting a reduction in their EPS estimates for 2026 and 2027. Truist downgraded the stock following disappointing Q2 results and a challenging medical cost trend environment. Barclays and Baird also reduced their price targets, with Barclays reacting to the Q2 report and Baird expressing caution regarding Medicaid and the healthcare exchange. These developments reflect broader concerns about cost pressures and uncertainties impacting Molina Healthcare’s financial performance.
Spark’s Take on MOH Stock
According to Spark, TipRanks’ AI Analyst, MOH is a Neutral.
Molina Healthcare’s stock score is primarily influenced by its robust financial performance and undervalued P/E ratio, suggesting potential for investment. However, bearish technical indicators and challenges highlighted in the earnings call, such as revised guidance and cost pressures, weigh down the overall score. Investors should remain cautious due to the mixed sentiment and technical downtrend.
To see Spark’s full report on MOH stock, click here.
More about Molina Healthcare
YTD Price Performance: -46.04%
Average Trading Volume: 1,231,993
Technical Sentiment Signal: Sell
Current Market Cap: $8.26B